Literature DB >> 19523767

HLA-B62 and HLA-DQ8 are associated with Complex Regional Pain Syndrome with fixed dystonia.

Annetje M de Rooij1, M Florencia Gosso, Geert W Haasnoot, Johan Marinus, Willem Verduijn, Frans H J Claas, Arn M J M van den Maagdenberg, Jacobus J van Hilten.   

Abstract

Complex Regional Pain Syndrome (CRPS) is clinically characterized by pain in combination with sensory, autonomic, and motor symptoms that may include weakness, tremor, myoclonus and dystonia of the affected limb(s). The syndrome is multifactorial in origin and mostly attributed to tissue injury. There is some evidence that the human leukocyte antigen (HLA) system plays a role in the pathophysiology of CRPS, but previous studies lacked power. Here we performed the most extensive study investigating the contribution of HLA alleles (i.e. HLA-A, HLA-B, HLA-DRB1, and HLA-DQB1) in 150 CRPS patients who also had fixed dystonia. HLA-B62 (OR=2.05 [95% CI 1.41-2.99], P=0.0005) and HLA-DQ8 (OR=1.75 [95% CI 1.20-2.57], P=0.005) were found significantly associated with CRPS and dystonia. The association remained significant after correction (HLA-B62 P(corrected) [P(c)] = 0.02 and HLA-DQ8 P(c)=0.04). The involvement of HLA-B62 and HLA-DQ8 in CRPS with dystonia may indicate that these HLA loci are implicated in the susceptibility or expression of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523767     DOI: 10.1016/j.pain.2009.05.015

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  25 in total

Review 1.  Clinical features and pathophysiology of complex regional pain syndrome.

Authors:  Johan Marinus; G Lorimer Moseley; Frank Birklein; Ralf Baron; Christian Maihöfner; Wade S Kingery; Jacobus J van Hilten
Journal:  Lancet Neurol       Date:  2011-07       Impact factor: 44.182

Review 2.  [Complex regional pain syndrome: A current review].

Authors:  C Maihöfner
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

Review 3.  [Complex regional pain syndrome following distal fractures of the radius : Epidemiology, pathophysiological models, diagnostics and therapy].

Authors:  L Harhaus; F Neubrech; C Hirche; T Schilling; H Kohler; A Mayr; A Riesmeier; B Bickert; U Kneser
Journal:  Unfallchirurg       Date:  2016-09       Impact factor: 1.000

4.  Complex regional pain syndrome: state of the art update.

Authors:  Patrick Henson; Stephen Bruehl
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04

Review 5.  Complex regional pain syndrome: a narrative review for the practising clinician.

Authors:  H Shim; J Rose; S Halle; P Shekane
Journal:  Br J Anaesth       Date:  2019-05-02       Impact factor: 9.166

Review 6.  Complex regional pain syndrome in children: asking the right questions.

Authors:  Kenneth R Goldschneider
Journal:  Pain Res Manag       Date:  2012 Nov-Dec       Impact factor: 3.037

Review 7.  New Concepts in Complex Regional Pain Syndrome.

Authors:  Maral Tajerian; John David Clark
Journal:  Hand Clin       Date:  2016-02       Impact factor: 1.907

8.  Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome.

Authors:  Wen-Wu Li; Tian-Zhi Guo; Xiaoyou Shi; Eva Czirr; Trisha Stan; Peyman Sahbaie; Tony Wyss-Coray; Wade S Kingery; J David Clark
Journal:  Pain       Date:  2014-09-10       Impact factor: 6.961

9.  Systematic mutation analysis of seven dystonia genes in complex regional pain syndrome with fixed dystonia.

Authors:  M Florencia Gosso; Annetje M de Rooij; Elisenda Alsina-Sanchis; Jessica T Kamphorst; Johan Marinus; Jacobus J van Hilten; Arn M J M van den Maagdenberg
Journal:  J Neurol       Date:  2010-01-12       Impact factor: 4.849

10.  The effectiveness and cost evaluation of pain exposure physical therapy and conventional therapy in patients with complex regional pain syndrome type 1. Rationale and design of a randomized controlled trial.

Authors:  Karlijn J Barnhoorn; Rob A B Oostendorp; Robert T M van Dongen; Frank P Klomp; Han Samwel; Gert Jan van der Wilt; Eddy Adang; Hans Groenewoud; Henk van de Meent; Jan Paul M Frölke
Journal:  BMC Musculoskelet Disord       Date:  2012-04-19       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.